Evelo Biosciences Inc

NASDAQ:EVLO   3:59:45 PM EDT
11.01
+0.83 (+8.15%)
Earnings Announcements

Evelo Biosciences Reports Q1 2021 Financial Results

Published: 04/29/2021 11:47 GMT
Evelo Biosciences Inc (EVLO) - Q1 Loss per Share $0.55.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.52

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.53

More details on our Analysts Page.